Enhanced in vivo sensitivity to interferon with in vitro resistant B16 tumor cells in mice.
Enhanced in vivo sensitivity to interferon with in vitro resistant B16 tumor cells in mice.
复制标题
增强小鼠体外抗性 B16 肿瘤细胞对干扰素的体内敏感性。
DOI:
10.1007/bf01533379
复制
发表时间:
1994
期刊:
影响因子:
--
通讯作者:
FleischmannJr,WR
中科院分区:
文献类型:
--
作者:
Fleischmann,CM;Stanton,GJ;FleischmannJr,WR
Mouse B16 melanoma cells rapidly develop resistance to the antiproliferative effects of interferon α (IFNα) and interferon β (IFNβ) when they are exposed to the interferons in vitro. This resistance was characterized to be non-genetic and dose-dependent, and does not alter other IFN-induced effects such as antiviral effects and elevation of 2′,5′-oligoadenylate synthetase activity in IFN-treated cells. The study of these IFN-resistant cells has been extended to an in vivo tumor model. Resistance, if it occurred in vivo, did not adversely affect the survival of IFN-treated mice. Further, IFN-treated mice inoculated with B16 cells that were resistant in vitro (B16αrescells) survived significantly longer than IFN-treated mice inoculated with B16 cells that were sensitive in vitro. The IFN-treated B16αres-inoculated mice had a significantly higher cure rate as well. The prolonged survival of the mice bearing B16αrescell tumors did not seem to be caused by the slower growth rate of the B16αrescells, since experiments performed with a tenfold higher B16αrescell inoculum and a tenfold lower B16 cell inoculum did not show any change in the survival pattern. It is clear that in vitro resistant B16αrescells are more sensitive to antitumor effects induced by IFN in vivo than in vitro sensitive B16 cells.